Team KINETA
Seattle's 2009 Walk MS
April 5, 2009

Please visit the MS Society web site
(www.MSwashington.org) for more information.

PRESS RELEASES
Kineta, Inc. is a privately held biotechnology company in Seattle founded in December 2007. Our team of world class scientists is developing unique drug therapies that enhance human response to infection and inflammation and harness the power of the immune system to fight disease. Kineta seeks to improve the lives of millions of people suffering from Type 1 diabetes, Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s and other diseases.  Our progressive business model focuses on careful management of capital and a strong return for investors. For more information on Kineta, Inc. visit our website, www.kinetabio.com

NEWS ARTICLES

• December 10, 2009 - Kineta Partner Awarded UC Discovery Grant to Advance Preclinical Studies on Lead Autoimmune Therapeutic
  
  
• November 10, 2009 - Kineta, University of Washington partner on NIH-funded project to develop vaccine immune boosters
  
  
• October 27, 2009 - Kineta Announces Collaboration, Receives Funding and Investments for Multiple Programs
  
  
• August 1, 2009 - Pharm Exec. Profiles Kineta in "Hot Biotech" Issue
  
  
• July 30, 2009 - Kineta Announces Strategic Alliance with Alturas Analytics
  
  
• July 7, 2009 - Kineta Acquires Novel Drug Candidates from Airmid for Potential Treatment of Multiple Sclerosis, Type 1 Diabetes and other Autoimmune Diseases
  
  
• March 15, 2009 - Kineta Inc. Executives Presenting at Invest Northwest
  
  
• February 9, 2009 - Ken North Named Senior Vice President of Finance
  
  
• October 8, 2008 - Kineta Receives SBIR Funding to Begin Novel Antiviral Research
  
  

MEDIA KIT
For updates on Kineta or to schedule interviews, please contact Bill Cadwallader by phone at 206-378-0400, or by email, bcadwallader@kinetabio.com